Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size By Test Type

  2.3.2 Market Size By Technology

  2.3.3 Market Size By Product Type

  2.3.4 Market Size By End User

        2.3.5 Market Size By Sample Type

 2.4 Market Share & Bps Analysis By Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

  3.4.1 Raw Application Suppliers

  3.4.2 Manufacturers

  3.4.3 Distributors/Suppliers

  3.4.4 Customers/End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

      4.1 Adoption & Usage Metrics

4.1.1 Percentage (%) of suspected dengue cases undergoing diagnostic testing.

4.1.2 Market share (%) of NS1 antigen vs. antibody-based vs. molecular tests.

4.1.3 Average number of dengue tests conducted per patient during diagnosis and monitoring.

4.1.4 Utilization trends (%) of rapid diagnostic tests vs. laboratory-based methods.

4.1.5 Growth (%) in dengue testing adoption in endemic vs. non-endemic regions.

     4.2 Operational & Performance Metrics

4.2.1 Diagnostic accuracy (%) of different dengue testing methods.

4.2.2 Sensitivity and specificity (%) across NS1, IgM/IgG, and PCR tests.

4.2.3 Turnaround time (TAT) for test results across different technologies.

4.2.4 Rate (%) of false positives/false negatives in various testing approaches.

4.2.5 Laboratory efficiency and testing capacity utilization rates.

     4.3 Technology & Innovation Metrics

4.3.1 Adoption (%) of advanced molecular diagnostic technologies (e.g., RT-PCR).

4.3.2 Development (%) of multiplex assays for simultaneous detection of dengue and other infections.

4.3.3 Integration (%) of point-of-care (POC) testing devices in remote and low-resource settings.

4.3.4 Number of ongoing clinical studies for improved dengue diagnostic methods.

4.3.5 Investment (%) in R&D for rapid, high-sensitivity, and cost-effective test kits.

    4.4 End-Use & Market Insights

4.4.1 Dengue incidence and prevalence rates influencing testing demand.

4.4.2 Demand trends across hospitals, diagnostic labs, and public health programs.

4.4.3 Impact of government screening initiatives and surveillance programs.

4.4.4 Availability and affordability of rapid diagnostic kits in developing regions.

4.4.5 Growth opportunities driven by increasing awareness and early diagnosis initiatives.

5. Dengue Testing Market Segmental Analysis & Forecast, By Test Type, 2022 – 2035, Value (USD Billion)

     5.1 Introduction

 5.2 NS1 Antigen Test

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022 – 2035

     5.3 IgM Antibody Test

     5.4 IgG Antibody Test

     5.5 RT-PCR Test

6. Dengue Testing Market Segmental Analysis & Forecast, By Technology, 2022 – 2035, Value (USD Billion)

    6.1 Introduction

    6.2 ELISA

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022 – 2035

    6.3 Rapid Diagnostic Tests (RDTs)

   6.4 PCR

    6.5 Others

7. Dengue Testing Market Segmental Analysis & Forecast, By Product Type, 2022 – 2035, Value (USD Billion)

    7.1 Introduction

    7.2 Test Kits

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022 – 2035

    7.3 Instruments

    7.4 Reagents & Consumables

    7.5 Others

8. Dengue Testing Market Segmental Analysis & Forecast, By End User, 2022 – 2035, Value (USD Billion)

    8.1 Introduction

 8.2 Hospitals

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022 – 2035

    8.3 Diagnostic Laboratories

    8.4 Public Health Laboratories

    8.5 Research Institutes

9. Dengue Testing Market Segmental Analysis & Forecast, By Sample Type, 2022 – 2035, Value (USD Billion)

        9.1 Introduction 

  9.2 Blood

   9.2.1 Key Trends 

   9.2.2 Market Size & Forecast, 2022 – 2035 

  9.3 Serum

         9.4 Plasma

10. Dengue Testing Market Segmental Analysis & Forecast By Region, 2022 – 2035, Value (USD Billion)

  10.1 Introduction

 10.2 North America

  10.2.1 Key Trends

  10.2.2 Dengue Testing Market Size & Forecast, By Test Type, 2022 – 2035

  10.2.3 Dengue Testing Market Size & Forecast, By Technology, 2022 – 2035

  10.2.4 Dengue Testing Market Size & Forecast, By Product Type, 2022 – 2035

  10.2.5 Dengue Testing Market Size & Forecast, By End User, 2022 – 2035

  10.2.6 Dengue Testing Market Size & Forecast, By Sample Type, 2022 – 2035

  10.2.7 Dengue Testing Market Size & Forecast, By Country, 2022 – 2035

   10.2.7.1 USA

   10.2.7.2 Canada

10.3 Europe

 10.3.1 Key Trends

 10.3.2 Dengue Testing Market Size & Forecast, By Test Type, 2022 – 2035

 10.3.3 Dengue Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.3.4 Dengue Testing Market Size & Forecast, By Product Type, 2022 – 2035

 10.3.5 Dengue Testing Market Size & Forecast, By End User, 2022 – 2035

 10.3.6 Dengue Testing Market Size & Forecast, By Sample Type, 2022 – 2035

 10.3.7 Dengue Testing Market Size & Forecast, By Country, 2022 – 2035

  10.3.7.1 Germany

  10.3.7.2 UK

  10.3.7.3 France

  10.3.7.4 Italy

  10.3.7.5 Spain

  10.3.7.6 Russia

  10.3.7.7 Poland

  10.3.7.8 Rest of Europe

10.4 Asia-Pacific

 10.4.1 Key Trends

 10.4.2 Dengue Testing Market Size & Forecast, By Test Type, 2022 – 2035

 10.4.3 Dengue Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.4.4 Dengue Testing Market Size & Forecast, By Product Type, 2022 – 2035

 10.4.5 Dengue Testing Market Size & Forecast, By End User, 2022 – 2035

 10.4.6 Dengue Testing Market Size & Forecast, By Sample Type, 2022 – 2035

 10.4.7 Dengue Testing Market Size & Forecast, By Country, 2022 – 2035

  10.4.7.1 China

  10.4.7.2 India

  10.4.7.3 Japan

  10.4.7.4 South Korea

  10.4.7.5 Australia

  10.4.7.6 ASEAN Countries

  10.4.7.7 Rest of Asia-Pacific

10.5 Latin America

 10.5.1 Key Trends

 10.5.2 Dengue Testing Market Size & Forecast, By Test Type, 2022 – 2035

 10.5.3 Dengue Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.5.4 Dengue Testing Market Size & Forecast, By Product Type, 2022 – 2035

 10.5.5 Dengue Testing Market Size & Forecast, By End User, 2022 – 2035

 10.5.6 Dengue Testing Market Size & Forecast, By Sample Type, 2022 – 2035

 10.5.7 Dengue Testing Market Size & Forecast, By Country, 2022 – 2035

  10.5.7.1 Brazil

  10.5.7.2 Argentina

  10.5.7.3 Mexico

  10.5.7.4 Colombia

  10.5.7.5 Rest of Latin America

10.6 Middle East & Africa

 10.6.1 Key Trends

 10.6.2 Dengue Testing Market Size & Forecast, By Test Type, 2022 – 2035

 10.6.3 Dengue Testing Market Size & Forecast, By Technology, 2022 – 2035

 10.6.4 Dengue Testing Market Size & Forecast, By Product Type, 2022 – 2035

 10.6.5 Dengue Testing Market Size & Forecast, By End User, 2022 – 2035

 10.6.6 Dengue Testing Market Size & Forecast, By Sample Type, 2022 – 2035

 10.6.7 Dengue Testing Market Size & Forecast, By Country, 2022 – 2035

  10.6.7.1 UAE

  10.6.7.2 Saudi Arabia

  10.6.7.3 Qatar

  10.6.7.4 Egypt

  10.6.7.5 South Africa

  10.6.7.6 Rest of Middle East & Africa

11. Competitive Landscape

 11.1 Key Players' Positioning

 11.2 Competitive Developments

  11.2.1 Key Strategies Adopted (%), By Key Players, 2025

  11.2.2 Year-Wise Strategies & Development, 2022 – 2025

  11.2.3 Number Of Strategies Adopted By Key Players, 2025

 11.3 Market Share Analysis, 2025

 11.4 Product/Service & Application Benchmarking

  11.4.1 Product/Service Specifications & Features By Key Players

  11.4.2 Product/Service Heatmap By Key Players

  11.4.3 Application Heatmap By Key Players

 11.5 Industry Start-Up & Innovation Landscape

11.6 Key Company Profiles

  11.6.1 Abbott Laboratories

  11.6.1.1 Company Overview & Snapshot

  11.6.1.2 Product/Service Portfolio

  11.6.1.3 Key Company Financials

  11.6.1.4 SWOT Analysis

11.6.2 Abbott Laboratories

11.6.3 Thermo Fisher Scientific

11.6.4 Danaher Corporation (Beckman Coulter)

11.6.5 Bio-Rad Laboratories, Inc.

11.6.6 Thermo Fisher Scientific Inc.

11.6.7 Becton, Dickinson and Company (BD)

11.6.8 bioMérieux SA

11.6.9 QuidelOrtho Corporation

11.6.10 SD Biosensor, Inc.

11.6.11 Fujirebio (H.U. Group Holdings)

11.6.12 InBios International, Inc.

11.6.13 CTK Biotech, Inc.

11.6.14 Standard Diagnostics, Inc.

11.6.15 J. Mitra & Co. Pvt. Ltd.

11.6.16 Premier Medical Corporation Ltd.

11.6.17 Arkray, Inc.

11.6.18 DiaSorin S.p.A.

11.6.19 Trinity Biotech plc

11.6.20 NovaTec Immundiagnostica GmbH

12. Analyst Recommendations

 12.1 SNS Insider Opportunity Map

 12.2 Industry Low-Hanging Fruit Assessment

 12.3 Market Entry & Growth Strategy

 12.4 Analyst Viewpoint & Suggestions On Market Growth

13. Assumptions

14. Disclaimer

15. Appendix

 15.1 List Of Tables

 15.2 List Of Figures